Iovance Biotherapeutics, Inc. (IOVA)
10.25
+0.23
(+2.30%)
USD |
NASDAQ |
Sep 18, 16:00
10.22
-0.03
(-0.29%)
After-Hours: 20:00
Iovance Biotherapeutics 30-Day Average Daily Volume : 15.89M for Sept. 18, 2026
30-Day Average Daily Volume Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| September 18, 2026 | 15.89M |
| September 17, 2026 | 17.58M |
| September 16, 2026 | 17.29M |
| September 15, 2026 | 16.99M |
| September 14, 2026 | 17.05M |
| September 11, 2026 | 17.02M |
| September 10, 2026 | 17.08M |
| September 09, 2026 | 17.08M |
| September 08, 2026 | 17.13M |
| September 04, 2026 | 17.26M |
| September 03, 2026 | 17.30M |
| September 02, 2026 | 17.14M |
| September 01, 2026 | 17.20M |
| August 31, 2026 | 17.65M |
| August 28, 2026 | 17.79M |
| August 27, 2026 | 18.32M |
| August 26, 2026 | 19.01M |
| August 25, 2026 | 20.13M |
| August 24, 2026 | 20.18M |
| August 21, 2026 | 20.10M |
| August 20, 2026 | 19.50M |
| August 19, 2026 | 18.50M |
| August 18, 2026 | 18.04M |
| August 17, 2026 | 18.07M |
| August 14, 2026 | 18.01M |
| Date | Value |
|---|---|
| August 13, 2026 | 18.11M |
| August 12, 2026 | 18.30M |
| August 11, 2026 | 18.19M |
| August 10, 2026 | 18.20M |
| August 07, 2026 | 18.41M |
| August 06, 2026 | 17.68M |
| August 05, 2026 | 15.75M |
| August 04, 2026 | 15.83M |
| August 03, 2026 | 15.86M |
| July 31, 2026 | 16.22M |
| July 30, 2026 | 15.93M |
| July 29, 2026 | 15.76M |
| July 28, 2026 | 15.82M |
| July 27, 2026 | 15.74M |
| July 24, 2026 | 15.68M |
| July 23, 2026 | 15.66M |
| July 22, 2026 | 15.71M |
| July 21, 2026 | 15.62M |
| July 20, 2026 | 15.59M |
| July 17, 2026 | 15.80M |
| July 16, 2026 | 15.34M |
| July 15, 2026 | 14.83M |
| July 14, 2026 | 13.85M |
| July 13, 2026 | 13.98M |
| July 10, 2026 | 13.85M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Amgen, Inc. | 2.718M |
| AVITA Medical, Inc. | 628696.4 |
| Halozyme Therapeutics, Inc. | 2.301M |
| Neurocrine Biosciences, Inc. | 1.156M |
| Editas Medicine, Inc. | 2.980M |